Epidemiological surveillance study of female genital mutilation in the UK.


Journal

Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434

Informations de publication

Date de publication:
04 2021
Historique:
received: 02 05 2020
revised: 16 08 2020
accepted: 31 08 2020
pubmed: 8 10 2020
medline: 21 5 2021
entrez: 7 10 2020
Statut: ppublish

Résumé

Describe cases of female genital mutilation (FGM) presenting to consultant paediatricians and sexual assault referral centres (SARCs), including demographics, medical symptoms, examination findings and outcome. The well-established epidemiological surveillance study performed through the British Paediatric Surveillance Unit included FGM on the monthly returns. All consultant paediatricians and relevant SARC leads across the UK and Ireland. Under 16 years old with FGM. Data on cases from November 2015 to November 2017 and 12 months later meeting the case definition of FGM. Returns included 146 cases, 103 (71%) had confirmed FGM and 43 (29%) did not meet the case definition. There were none from Northern Ireland. The mean reported age was 3 years. Using the WHO classification of FGM, 58% (n=60) had either type 1 or type 2, 8% (n=8) had type 3 and 21% (n=22) had type 4. 13% (n=13) of the cases were not classified and none had piercings or labiaplasty. The majority, 70% had FGM performed in Africa with others from Europe, Middle East and South-East Asia. There were few physical and mental health symptoms. Only one case resulted in a successful prosecution. There were low numbers of children presenting with FGM and in the 2 years there was only one prosecution. The findings may be consistent with attitude changes in FGM practising communities and those at risk should be protected and supported by culturally competent national policies.

Identifiants

pubmed: 33023890
pii: archdischild-2020-319569
doi: 10.1136/archdischild-2020-319569
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

372-376

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Deborah Hodes (D)

Department of Paediatrics, University College London Hospitals NHS Foundation Trust, London, UK deborah.hodes@nhs.net.

Najette Ayadi O'Donnell (N)

Department of Paediatrics, University College London Hospitals NHS Foundation Trust, London, UK.

Karina Pall (K)

BPSU, Royal College of Paediatrics and Child Health, London, UK.

Marina Leoni (M)

BPSU, Royal College of Paediatrics and Child Health, London, UK.

Wingsan Lok (W)

BPSU, Royal College of Paediatrics and Child Health, London, UK.

Geoff Debelle (G)

Child Protection, Birmingham Women's and Children's Hospitals NHS Foundation Trust, Birmingham, UK.

Alice Jane Armitage (AJ)

Department of Paediatrics, University College London Hospitals NHS Foundation Trust, London, UK.

Sarah M Creighton (SM)

Women's Health, University College London Hospitals NHS Foundation Trust, London, UK.

Richard M Lynn (RM)

BPSU, Royal College of Paediatrics and Child Health, London, UK.
Department of Epidemiology and Public Health, Institue Of Child Health, University College London Research, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH